Phenylalanine

Phenylalanine

SCHEMBL531086

CC(C)[C@H](N)C(=O)O.N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 7/20 0.76
ALPI P09923 1/20 0.76
PKM P14618 1/20 0.76
PTGS1 P23219 1/20 0.76
XIAP P98170 1/20 0.76
SLC1A3 P43003 2/20 0.59
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
SLC15A1 P46059 1/20 0.51
NOS3 P29474 1/20 0.51
NOS1 P29475 1/20 0.51
NOS2 P35228 1/20 0.51
SLC6A2 P23975 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
ANPEP P15144 2/20 0.50
RNPEP Q9H4A4 2/20 0.50
DNPEP Q9ULA0 2/20 0.50
MAOA P21397 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Phenylalanine SCHEMBL28257181 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
D-Phenylalanine SCHEMBL28257178 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28144022 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL1679190 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL6237224 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL8595582 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL4283680 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL4283687 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL6535452 0.97 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL6274269 0.97 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024140917-A1 ANTI-CD40 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 上海盛迪医药有限公司 2024-07-04 WO claimed
EP-4374879-A1 DRUG CONJUGATE OF ERIBULIN DERIVATIVE Shanghai Senhui Medicine Co., Ltd. (CN) 2024-05-29 EP claimed
CN-118103359-A Preparation method of eribulin derivative 江苏恒瑞医药股份有限公司 2024-05-28 CN claimed
CN-117460540-A Pharmaceutical conjugates of eribulin derivatives 上海森辉医药有限公司 2024-01-26 CN claimed
WO-2023143351-A1 DRUG CONJUGATE OF GLUCOCORTICOID 上海盛迪医药有限公司 2023-08-03 WO claimed
US-20230227696-A1 COMPOSITION FOR SEMICONDUCTOR PROCESS, METHOD FOR PREPARING THE SAME AND METHOD FOR PREPARING SEMICONDUCTOR DEVICE USING THE SAME YCCHEM CO., LTD. (KR) 2023-07-20 US claimed
WO-2023124963-A1 ANTIBODY-DRUG CONJUGATE HAVING REDUCED REVERSIBLE REACTION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 昆山新蕴达生物科技有限公司 2023-07-06 WO claimed
EP-4190812-A1 ANTI-CD79B ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2023-06-07 EP claimed
CN-115845080-A Eribulin derivative-anti-folate receptor antibody conjugate 上海森辉医药有限公司 2023-03-28 CN claimed
CN-115698079-A anti-CD 79B antibody drug conjugate, preparation method and medical application thereof 上海拓界生物医药科技有限公司 2023-02-03 CN claimed
US-6080887-A HEATING A MIXTURE COMPRISING THE RACEMIC MIXTURE WITH AT LEAST ONE ALKALI OR ALKALINE EARTH SALT OF N-ACETYL-D(L)-.ALPHA.-AMINO CARBOXYLIC ACID AND ACETIC ANHYDRIDE UNDER NON-AQUEOUS CONDITIONS DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-06-27 US claimed
JP-2000501387-A 2000-02-08 JP claimed
WO-1999029311-A1 HIV/FIV PROTEASE INHIBITORS HAVING A SMALL P3 RESIDUE THE SCRIPPS RESEARCH INSTITUTE (US) 1999-06-17 WO claimed
EP-0876329-A1 PROCESS FOR THE PRODUCTION OF N-ACETYL-D,L-ALPHA-AMINOCARBOXYLIC ACIDS Degussa Aktiengesellschaft (DE) 1998-11-11 EP claimed
EP-0874801-A1 PROCESS FOR OBTAINING OPTICALLY ACTIVE L-ALPHA-AMINOCARBOXYLIC ACIDS FROM CORRESPONDING RACEMIC D,L-ALPHA-AMINOCARBOXYLIC ACIDS Degussa Aktiengesellschaft (DE) 1998-11-04 EP claimed
EP-0873290-A1 PROCESS FOR RACEMIZATION OF N-ACETYL-D(L)-ALPHA-AMINOCARBOXYLIC ACIDS Degussa Aktiengesellschaft (DE) 1998-10-28 EP claimed
WO-1997021650-A1 PROCESS FOR RACEMIZATION OF N-ACETYL-D(L)-ALPHA-AMINOCARBOXYLIC ACIDS DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-06-19 WO claimed
WO-1997021667-A1 PROCESS FOR THE PRODUCTION OF N-ACETYL-D,L-ALPHA-AMINOCARBOXYLIC ACIDS DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-06-19 WO claimed
WO-1997021663-A1 PROCESS FOR OBTAINING OPTICALLY ACTIVE L-ALPHA-AMINOCARBOXYLIC ACIDS FROM CORRESPONDING RACEMIC D,L-ALPHA-AMINOCARBOXYLIC ACIDS DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-06-19 WO claimed
EP-0374097-A2 Use of peptide isosteres as retroviral protease inhibitors CIBA-GEIGY AG (CH) 1990-06-20 EP claimed